[go: up one dir, main page]

AU1856297A - Lyst1 and lyst2 gene compositions and methods of use - Google Patents

Lyst1 and lyst2 gene compositions and methods of use

Info

Publication number
AU1856297A
AU1856297A AU18562/97A AU1856297A AU1856297A AU 1856297 A AU1856297 A AU 1856297A AU 18562/97 A AU18562/97 A AU 18562/97A AU 1856297 A AU1856297 A AU 1856297A AU 1856297 A AU1856297 A AU 1856297A
Authority
AU
Australia
Prior art keywords
lyst2
lyst1
methods
gene compositions
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU18562/97A
Other versions
AU718378B2 (en
Inventor
Maria D. F. S. Barbosa-Alleyne
Stephen F. Kingsmore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Florida
Original Assignee
University of Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Florida filed Critical University of Florida
Publication of AU1856297A publication Critical patent/AU1856297A/en
Application granted granted Critical
Publication of AU718378B2 publication Critical patent/AU718378B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU18562/97A 1996-02-01 1997-01-31 LYST1 and LYST2 gene compositions and methods of use Ceased AU718378B2 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US1114696P 1996-02-01 1996-02-01
US60/011146 1996-02-01
US3359996P 1996-12-20 1996-12-20
US60/033599 1996-12-20
US3434696P 1996-12-23 1996-12-23
US60/034346 1996-12-23
PCT/US1997/001748 WO1997028262A1 (en) 1996-02-01 1997-01-31 Lyst1 and lyst2 gene compositions and methods of use

Publications (2)

Publication Number Publication Date
AU1856297A true AU1856297A (en) 1997-08-22
AU718378B2 AU718378B2 (en) 2000-04-13

Family

ID=27359378

Family Applications (1)

Application Number Title Priority Date Filing Date
AU18562/97A Ceased AU718378B2 (en) 1996-02-01 1997-01-31 LYST1 and LYST2 gene compositions and methods of use

Country Status (4)

Country Link
EP (1) EP0880586A1 (en)
JP (1) JP2002514897A (en)
AU (1) AU718378B2 (en)
WO (1) WO1997028262A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109112211A (en) * 2018-05-15 2019-01-01 广州达瑞生殖技术有限公司 A kind of the primer combination and method of human embryos Chediak-Higashi syndrome LYST detection in Gene Mutation

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2317922A1 (en) 1998-02-23 1999-08-26 Rigel Pharmaceuticals, Inc. Exo1 and exo2, exocytotic proteins
JP2002510490A (en) * 1998-04-03 2002-04-09 キュラジェン コーポレイション LYST protein complex and LYST interacting protein
JP2006042802A (en) * 2004-06-28 2006-02-16 Sumitomo Chemical Co Ltd Hypoxanthine guanine phosphoribosyltransferase gene from common marmoset and use thereof
JP2011509156A (en) 2008-01-08 2011-03-24 イェール ユニバーシティ Compositions and methods for promoting patency of vascular grafts
RU2728703C2 (en) * 2014-05-02 2020-07-31 Рисерч Инститьют Эт Нэшнуайд Чилдрен`С Хоспитал Compositions and methods for anti-lyst immunomodulation
JP6957468B2 (en) 2015-12-11 2021-11-02 リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル Systems and Methods for Optimized Patient-Specific Tissue Manipulation Vascular Grafts

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109112211A (en) * 2018-05-15 2019-01-01 广州达瑞生殖技术有限公司 A kind of the primer combination and method of human embryos Chediak-Higashi syndrome LYST detection in Gene Mutation

Also Published As

Publication number Publication date
EP0880586A1 (en) 1998-12-02
JP2002514897A (en) 2002-05-21
AU718378B2 (en) 2000-04-13
WO1997028262A1 (en) 1997-08-07

Similar Documents

Publication Publication Date Title
AU4008495A (en) Tcl-1 gene and protein and related methods and compositions
AU6079598A (en) Additive preparation and method of use thereof
AU1532297A (en) Starch-emulsifier composition and methods of making
AU2757097A (en) Method of coating and compositions for use therein
AU5693698A (en) Improved electrodes and method of use
AU3850395A (en) Hemorrhoidal compositions and method of use
AU5699799A (en) Makeup compositions and methods of making same
AU4597297A (en) Trans-sodium crocetinate, methods of making and methods of use thereof
AU1616499A (en) Chemokine variants and methods of use
AU1390199A (en) Compositions and methods for inhibiting the activity of certain genes
AU9301998A (en) Composition and methods using galectin-1
AU3118297A (en) Sok-1 and methods of use
AU2289495A (en) Dihydropyrimidine dehydrogenase compositions and methods of use
AU1841195A (en) 1-beta -methyl-carbapenem, compositions containing same and methods of use
AU1939895A (en) Enzymatic debridement compositions and methods
AU3730497A (en) Compositions and articles of manufacture
AU1856297A (en) Lyst1 and lyst2 gene compositions and methods of use
AU6412599A (en) Oxybutynin formulations and methods of use
AU3200197A (en) New composition and methods
AU3350197A (en) Mixture of esters and use thereof
AU5456898A (en) Compositions and articles of manufacture
AU3389197A (en) $(d)-erythroid kruppel-like factors and methods of use
AUPO982097A0 (en) Methods and compositions for use therein
AU2556195A (en) CD40 binding compositions and methods of using same
AU4839100A (en) Methods of using and compositions comprising n-desmethylzolpidem

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired